Cargando…
Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective
This analysis shows the economic benefit of antihypertensive treatment in patients 80 years of age or older from the perspective of the Swiss healthcare system. The cost-effectiveness analysis of antihypertensive treatment in the elderly was carried out applying the results of the Hypertension in th...
Autores principales: | Szucs, T D, Waeber, B, Tomonaga, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011095/ https://www.ncbi.nlm.nih.gov/pubmed/19536166 http://dx.doi.org/10.1038/jhh.2009.47 |
Ejemplares similares
-
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
por: Warwick, Jane, et al.
Publicado: (2015) -
Modelling Cognitive Decline in the Hypertension in the Very Elderly Trial [HYVET] and Proposed Risk Tables for Population Use
por: Peters, Ruth, et al.
Publicado: (2010) -
Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
por: Bulpitt, Christopher J, et al.
Publicado: (2006) -
Economic burden of symptomatic iron deficiency – a survey among Swiss women
por: Blank, Patricia R., et al.
Publicado: (2019) -
UniversitätsSpital Zürich: 80 years of neurosurgical patient care in Switzerland
por: Stienen, Martin N., et al.
Publicado: (2017)